ketamine analog ER 12hour tablet (KA-­ER12) / Amorsa Therap, J&J - LARVOL DELTA

Beaumont Health expert Matthew Sims, M.D. Ph.D., available to speak about President Trump’s COVID diagnosis. Dr. Sims is the director of Infectious Disease Research and an experienced media source (Newswise) - "Matthew Sims, M.D...can discuss President Trump's COVID-19 diagnosis. He has spoken to local and national media on dozens of topics throughout the pandemic, including two recent research projects in which he is the lead investigator. The first is the largest COVID serology study to launch as of April 13 and the second, SINK COVID is looking at how two common drugs-naltrexone and ketamine can be used to successfully treat the virus."

Interview • Novel Coronavirus Disease

Jay Joshi, MD: Ketamine, COVID-19, and the Real Crises of Pain Management (HCPLive) - "In an interview with HCPLive, program cochair Jay Joshi, MD...discussed the program agenda for the program, his own experience with pain management in the COVID-19 era, and current controversial topics in the field...HCPLive: Ketamine has really made strides in recent years, not just in academic assessment, but in clinical embrace. Joshi: I've lectured nationally on ketamine infusions. Just a few years back when I was lecturing, people would look at me like I'm crazy, I'm from Mars, just like back in 1999, while I was in medical school, I was the first to predict the Oxycontin epidemic. I'm very used to talking about things way before everyone else."

Interview

"Interesting journal club by @JHUPCCMFellows @kapper12 Tune in!" (@NadiaHanselMD)

".@JHUPCCMFellows taking in some history @SixthFlrMuseum after #ATS2019 sessions @VTejwaniMD @kapper12 @IanOppenheim" (@AshFawzyMD)

"Excellent meeting of the #ATS2019 Society for Sabermetrics (go Rangers) @kapper12" (@IanOppenheim)